MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202637024562 A) filed by Rigerna Therapeutics Co. , Ltd. on March 02, 2026, for Inhbe Gene-Targeted Double-Stranded Oligonucleotide, Conjugate, Composition And Use Thereof.
Inventors include Huang, Yuanyu; Li, Haitao; and Kong, Lina.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: Provided are an INHBE gene-targeted double-stranded oligonucleotide, a conjugate, and a composition, which relate to the technical field of nucleic acid drugs. The double-stranded oligonucleotide comprises a sense strand and an antisense strand. The antisense strand is complementary or substantially complementary to the sen...